Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanofi SA and Curie Cancer Cooperate on Research on Ovarian Cancer

Wednesday, 19 Jun 2013 01:01am EDT 

Sanofi SA and the Curie Institute, through its Curie-Cancer partnership under the Institut Carnot label, announced the establishment of a three-year research collaboration to identify new therapeutic targets for the development of treatments for ovarian cancer. The aim of the collaboration between Sanofi and Curie-Cancer is to revisit the basic biology of this type of cancer through a translational research approach. The Institut Curie has a collection of cryopreserved tumor samples that are well characterized clinically, histologically and biologically. These can be analyzed to identify biological targets relevant to the effective treatment of certain types of cancer. Through this collaboration, Sanofi and Curie-Cancer expect to gain a better understanding of the molecular alterations that characterize many types of ovarian cancer, thereby enabling effective new drugs to be designed. 

Company Quote

-0.08 -0.09%
11:35am EDT